Results

Total Results: 1,147 records

Showing results for "event".

141. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2008
     December 30, 2013 - heart disease will realize a small benefit from treatment, as seen inthe risk reduction in 10-year CHD event … disease was 59% lower than the rate in 1950. 2 The lifetime risk of having a coronary heart disease event … conflicting results, with some studies showing no benefit and others showing some coronary heart disease event

142. Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication
     November 13, 2016 - For example, in the JUPITER trial, the NNT to prevent 1 cardiovascular event was 94 in people younger … 52 35 White, 96 LDL-C: 157 HDL-C: 39 TC: 224 Triglycerides: 120 Prior CVD event

143. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - For example, in the JUPITER trial, the NNT to prevent 1 cardiovascular event was 94 in people younger … 52 35 White, 96 LDL-C: 157 HDL-C: 39 TC: 224 Triglycerides: 120 Prior CVD event

144. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Estimates used combined RRs from the meta-analyses and combined event rates from placebo groups of included … Combined event rates were determined from a meta-analysis of placebo event rates from each trial by using … 95% CIs were estimated using a simulation method that assumed that the logs of both the RRs and the event … Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women … Intended treatment duration is 5 years or until a breast, neoplastic, cardiovascular, or toxicity event

145. Draft Recommendation: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/obstructive-sleep-apnea-adults-screening
     March 29, 2022 - in progress Draft Recommendation Statement Obstructive Sleep Apnea in Adults: Screening March 29, 2022 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Depar…

146. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gXnmnkofo8FxoLnCmXJDjb
     October 01, 2009 - pooled data from 6 of these studies showed a risk ratio of 1.24 (CI, 1.01 to 1.51) for any CHD or CVD event

147. Final Research Plan: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     September 05, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication September 05, 2019 Recommendations made…

148. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
     December 12, 2017 - Third, low event rates also limited conclusions for some outcomes. … Likewise, event rates for cervical and endometrial cancers were low, rendering wide confidence intervals … Estimated Event Rate Increase (Harm) or Decrease (Benefit) per 10,000 Person-Years Associated With the … Use of Hormone Therapy Outcome Event Rate Difference, per 10,000 Person-Years (95% … Imprecise Undetected None Low Menopausal Women Without Intact Uterus 1 RCT 77 ; 1 event

149. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - Third, low event rates also limited conclusions for some outcomes. … Likewise, event rates for cervical and endometrial cancers were low, rendering wide confidence intervals … Estimated Event Rate Increase (Harm) or Decrease (Benefit) per 10,000 Person-Years Associated With the … Imprecise Undetected None Low Menopausal Women Without Intact Uterus 1 RCT 77 ; 1 event … significant increase with HT in WHI (HR, 1.37; 95% CI, 1.07-1.76) Risk of any cerebrovascular event

150. Nz Rqwxmmr8Vym-Yjuqru- (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZ_RQWxMMR8Vym-yJuqru-
     May 23, 2019 - After 10 years, more than 20% of such persons will have had a major cardiovascular event (for example … vs. 14.6% (P � 0.011) NR 1.3 events/100 person-years vs. 0.6 events/100 person-years for major CVD event … Number Needed To Screen for Diabetes To Prevent One Adverse Event* Prevalence of Undiagnosed Diabetes … same as relative risk reduction for photocoagulation (10). ‡ Assumptions: 7.5% 5-year risk for CVD event … With less favorable assump- tions, the NNS calculations for preventing one CVD event are still lower

151. Archived: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2003
     February 04, 2003 - infarction, stroke, and revascularization) from 25 percent to 20 percent, i.e., prevents one major vascular event … with hypertension or hyperlipidemia, however, the number needed to screen to prevent a cardiovascular event

152. Final Recommendation Statement: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/obstructive-sleep-apnea-in-adults-screening
     November 15, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Obstructive Sleep Apnea in Adults: Screening November 15, 2022 Recommendations made by the USPSTF are independent of the U.S. government. They sho…

153. Recommendation: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-anxiety-children-adolescents
     October 11, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Anxiety in Children and Adolescents: Screening October 11, 2022 Recommendations made by the USPSTF are independent of the U.S. government. Th…

154. Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DxeDM5ywg2J7SwKmETXfbX
     May 01, 2021 - Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement Screening for Obstructive Sleep Apnea in Adults US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Summary of Recommendation See the Summary of Recommendation figure.…

155. U.S. Preventive Services Task Force Issues Final Research Plan for Aspirin Use for the Primary Prevention of Cancer and Aspirin Use for the Primary Prevention of Cardiovascular Events | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-research-plan-aspirin-use-primary-prevention-cancer-and-aspirin-use-primary-prevention
     October 18, 2013 - U.S. Preventive Services Task Force Issues Final Research Plan for Aspirin Use for the Primary Prevention of Cancer and Aspirin Use for the Primary Prevention of Cardiovascular Events Share to Facebook Share to X Share to WhatsApp Share to Email Print …

156. Ninth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
     January 01, 2019 - diabetes, hypertension, or smoking); and 3) they have a calculated 10-year risk of a cardiovascular event … Identification of dyslipidemia and calculation of 10-year CVD event risk requires universal lipids … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected

157. Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/lipid-disorders-children-adolescents-screening
     August 19, 2021 - Share to Facebook Share to Twitter Share to WhatsApp Share to E-mail Print in progress Final Research Plan Lipid Disorders in Children and Adolescents: Screening August 19, 2021 Recommendations made by the USPSTF …

158. Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/lipid-disorders-in-children-screening
     August 19, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Lipid Disorders in Children and Adolescents: Screening August 19, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They shou…

159. Szn5Hhs8W5Sar6Bbpabsab (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
     June 01, 2008 - A substantial proportion of persons presenting with a new cardiovascular event have undiagnosed diabetes … the non- diabetes subgroup benefited from statin treatment in re- ducing mortality or cardiovascular event … This fair-quality study was stopped early, with a resultant low event rate in both groups. … Diabetes Prevention Program) (36), neither the cumulative incidence of cardiovascular disease nor the event … 1 Eye (Screening 1000 People with Given Prevalence) Tight Blood Pressure Control to Prevent 1 CVD Event

160. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - A substantial proportion of persons presenting with a new cardiovascular event have undiagnosed diabetes … nor the nondiabetes subgroup benefited from statin treatment in reducing mortality or cardiovascular event … This fair-quality study was stopped early, with a resultant low event rate in both groups. … Diabetes Prevention Program) 36 , neither the cumulative incidence of cardiovascular disease nor the event … Cumulative incidence of CVD and CVD event rate: NSD among groups, but underpowered for this outcome.